Is BEAT or CARL more undervalued in 2026?

CirclFi compares Heartbeam, Inc. (BEAT) and Carlsmed, Inc. (CARL) using 13 institutional-grade valuation models. BEAT has a Quality of Company score of 4.0/10 while CARL scores 6.6/10.

Which is a better buy — BEAT or CARL?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BEAT and CARL valuations compare?

BEAT at $0.90 and CARL at $11.81 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BEAT vs CARL Valuation Comparison 2026 — Intrinsic Value Analysis

BEAT

Health Information Services

Heartbeam, Inc.

Quality

4.0

out of 10

Value Trap

SAFE

Price

$0.90

Last close

Models

6/13

Active

CARL

Health Information Services

Carlsmed, Inc.

Quality

6.6

out of 10

Value Trap

—

Price

$11.81

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	BEAT Fair Value	BEAT Upside	CARL Fair Value	CARL Upside
Bayesian DCF	Intrinsic	$0.26	-71.0%	$4.52	-61.7%
Earnings Power Value	Intrinsic	—	—	$6.69	-29.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.18	-80.3%	$3.81	-67.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BEAT vs CARL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BEAT vs CARL — Which Stock Is More Undervalued?

CARL scores higher with a 6.6/10 quality rating vs BEAT's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Heartbeam, Inc. (BEAT) and Carlsmed, Inc. (CARL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BEAT currently trades at $0.90 with a QOC of 4.0/10, while CARL trades at $11.81 with a QOC of 6.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).